.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Apollo Hospitals Enterprise Limited recently announced the Apollo Hospitals Q4 results, highlighting a robust financial performance. Specifically, the corporate hospital chain reported an 18% year-on-year increase in consolidated revenue, reaching Rs 6,605 crore. Additionally, the company's net profit climbed 36% to Rs 529 crore compared to Rs 390 crore in the previous fiscal year. This impressive growth reflects a rising demand for healthcare services across India.
Meanwhile, the operating margins for the hospital's base business contracted slightly to 23.8%. However, overall bed occupancy rose to 68% as the chain expanded its capacity to 8,131 beds. Consequently, average revenue per patient saw healthy gains, particularly in Karnataka where it reached Rs 1.95 lakh. Furthermore, the retail healthcare and diagnostic divisions reported strong gross revenues of Rs 489 crore. Therefore, these operational improvements contributed significantly to the successful quarterly outcomes.
To support this expansion, Apollo launched four new hospitals during the second half of the fiscal year. Moreover, the group is currently developing upcoming projects in Hyderabad and Sonarpur, Kolkata. Consequently, these new facilities will enhance healthcare access across multiple regions. In addition, the board approved a demerger of its pharmacy and digital health businesses. The group targets this potential listing for Q4 FY27, subject to necessary regulatory approvals.
Q1: What was the consolidated revenue for Apollo Hospitals in Q4 FY26?
The consolidated revenue for the quarter stood at Rs 6,605 crore, representing an 18% year-on-year increase.
Q2: Where is Apollo constructing its new hospitals?
Apollo is currently executing upcoming hospital projects in Hyderabad and Sonarpur, Kolkata, after launching four facilities recently.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Apollo Hospitals Q4 results show a 36% rise in net profit to Rs 529 crore, driven by robust operational growth and upcoming medical expansions....
3 months ago
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
